Navigation Links
PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad

ProductsPROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
Company Bio-Rad
Item PROTEAN II xi Cell, 16 cm, without spacers and combs
Price 
Description The PROTEAN II xi cell, 16 cm, is used for vertical slab gel electrophoresis of nucleic acids and proteins in agarose gels. The cell is supplied without spacers and combs. The unit includes a central cooling core with gaskets, lower buffer chamber, lid with cables, 2 sets of glass plates, 4 sandwich clamps, upper buffer dam, casting stand with gaskets, leveling bubble, and instructions.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
2. PROTEAN II xi Cell, 20 cm, without spacers and combs from Bio-Rad
3. PROTEAN II XL Cell, wide format from Bio-Rad
4. PROTEAN II xi Multi-Cell from Bio-Rad
5. PROTEAN II XL Cell, wide format, 2.0 mm from Bio-Rad
6. PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
7. PROTEAN II xi Cell 2-D Conversion Kit. from Bio-Rad
8. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
9. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
10. PROTEAN II xi 2-D Cell from Bio-Rad
11. PROTEAN II Slab Gel Casting Stand, with gaskets from Bio-Rad
SHEEP ANTI HUMAN CATHEPSIN G...
...
MOUSE ANTI BOVINE CD335:ALEXA 488 Immunogen: Fusion protein consisting of the extracellular region of bovine CD335....
Human Aminopeptidase P1/XPNPEP1 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Biology Products:
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2
... may not be enough to experience significant health benefits, ... activity such as walking alone is not likely going ... that occasionally elevate the intensity," said Dr. Vicki Harber, ... presented recently at the American College of Sports Medicine ...
... sepsis, a fast-moving blood infection that is a leading ... illness unleashes a powerful inflammatory response that can quickly ... within days. , With a narrow window of opportunity ... typically rush to prescribe powerful antibiotics, even before laboratory ...
... complete with her brood of some 20 eggs and 2 ... part anatomy including legs and eyes. , The research team ... Siveter from Oxford, Mark Sutton from Imperial College London and ... made a digital image of the fossil - an ostracod ...
Cached Biology News:Walking not enough for significant exercise benefits 2Gene chip technology shows potential for identifying life-threatening blood infection 2Gene chip technology shows potential for identifying life-threatening blood infection 3Gene chip technology shows potential for identifying life-threatening blood infection 4
(Date:5/21/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... develops and commercializes proprietary technologies and products for advanced ... for the second fiscal quarter ended March 31, 2015. ... to advance business with our existing customers and to ... and CEO of SQI. "The delivery of a fully ...
(Date:5/21/2015)... uBiome, the leading startup focused ... PicnicHealth, a healthcare company that collects and consolidates ... Bowel Disease (IBD) will receive a complementary PicnicHealth ... kit. Both companies were funded by Y Combinator ... more information on this partnership and how to ...
(Date:5/21/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced positive updated results from its ... the treatment of unresectable glioblastoma multiforme (GBM), a ... trial is designed to investigate the preliminary efficacy ... have progressed following prior treatment with surgery, radiation ...
(Date:5/21/2015)... PA (PRWEB) May 21, 2015 ... has joined the firm as senior statistician and Principal, ... years of experience in the management and analysis of ... pharmaceutical and chemical industries. , “We’re delighted to have ... capabilities in data analytics,” said Dr. Philippe Cini, Group ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2